William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ): "continue to believe VIZZ holds blockbuster potential"
Tweet Send to a Friend
William Blair analyst Lachlan Hanbury-Brown reiterated an Outperform rating on LENZ Therapeutics Inc (NASDAQ: LENZ)The analyst commented, "We believe VIZZ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
